National Inpatient Sample

Evidence quality

Other

Highlighted claims

• The NIS is the largest publicly available all-payer inpatient database in the United States. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• The NIS includes roughly 20% of hospitalisations from participating hospitals and uses weighting to estimate national totals. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• The study used NIS data from 2015 to 2021. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• The NIS does not contain detailed clinical data such as laboratory values, imaging, or liver biopsy results, limiting the study's analytical depth. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• The retrospective design of the study prevents causal inference. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample
• The use of a large, nationally representative administrative database improves the generalisability of the findings. — Racial and Socioeconomic Determinants of Major Adverse Liver Outcomes in Patients with Coexisting Inflammatory Bowel Disease and Chronic Liver Disease: Insights from the National Inpatient Sample